Join our smart investors - Get the best stock directories in  blockchain, cannabis, crypto, AI, IoT, cleantech. Daily podcasts in cannabis and crpto. Just $99  a year

CSE New Listing - Izotropic Corporation (IZO)

 

May 30, 2018 (Investorideas.com Newswire) The common shares of Izotropic Corporation have been approved for listing on the CSE. Listing and disclosure documents will be available at www.thecse.com on the trading date.

The Company is engaged in the commercialization of proprietary diagnostic products for breast cancer. Its business strategy is to complete the commercial development of 360 degree, true 3D breast imaging technology for early diagnosis of breast cancer. The Company holds a license under a license agreement to make, have made, use, offer for sale, import, and sell products and services and to practice processes and methods in the field of human diagnostics and therapeutics in the United States and any other countries where approvals are granted or where patent rights may exist in the future with respect to certain licensed patent rights.


BiotechIndustryStocks.com - A Leading Global Investor Website for Biotech Industry Stocks

BiotechIndustryStocks.com - investing ideas in biotechnology stocks, medical technology and life sciences

Like Biotech Stocks? View our Biotech Stocks Directory

Get News Alerts on Biotech Stocks


Les actions ordinaires de Izotropic Corporation ont été approuvées pour inscription à la cote du CSE.

Les documents d'inscription et de divulgation seront disponibles sur www.thecse.com à la date de négociation.

La Société est engagée dans la commercialisation de produits de diagnostic exclusifs pour le cancer du sein. Sa stratégie commerciale consiste à compléter le développement commercial de la technologie d'imagerie mammaire 3D à 360 degrés pour le diagnostic précoce du cancer du sein. La Société détient une licence en vertu d'un contrat de licence pour fabriquer, fabriquer, utiliser, mettre en vente, importer et vendre des produits et services et pour pratiquer des procédés et méthodes dans le domaine du diagnostic et de la thérapeutique humaine aux États-Unis et dans tout autre pays lorsque des approbations sont accordées ou lorsque des droits de brevet peuvent subsister à l'avenir en ce qui concerne certains droits de brevet sous licence.


If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com

The Canadian Securities Exchange, or CSE, is operated by CNSX Markets Inc. Recognized as a stock exchange in 2004, the CSE began operations in 2003 to provide a modern and efficient alternative for companies looking to access the Canadian public capital markets. http://thecse.com/


Investorideas.com is a listed service provider on the Canadian Securities Exchange http://thecse.com/en/services/services-for-listed-companies/investorideascom

More Info:

Investorideas.com Newswire

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire https://www.investorideas.com/News-Upload/

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp